SCHEMBL1894034

SCHEMBL1894034

N#Cc1cnc2ccc(N)cc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.53
HPGDS O60760 2/20 0.47
HTT P42858 3/20 0.46
KDM4E B2RXH2 3/20 0.46
ALDH1A1 P00352 2/20 0.46
TP53 P04637 1/20 0.46
HSP90AA1 P07900 1/20 0.46
HSP90AB1 P08238 1/20 0.46
MAPT P10636 1/20 0.46
TSHR P16473 1/20 0.46
CASP1 P29466 1/20 0.46
ATM Q13315 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HSD17B10 Q99714 1/20 0.46
MDM4 O15151 1/20 0.43
CDC7 O00311 1/20 0.43
MAP4K4 O95819 4/20 0.41
APP P05067 1/20 0.41
PLAU P00749 1/20 0.40
TLR9 Q9NR96 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21689072 0.86 HPGDS (0.59) EGFRHPGDSHTTKDM4EALDH1A1
SCHEMBL3879836 0.79 HPGDS (0.47) HPGDSHTTKDM4EALDH1A1CDC7
SCHEMBL12850560 0.79 HPGDS (0.47) HPGDSHTTKDM4EALDH1A1CDC7
SCHEMBL4949489 0.79 HPGDS (0.47) HPGDSHTTALDH1A1CDC7MAP4K4
SCHEMBL15125079 0.79 HPGDS (0.51) HPGDSKDM4EALDH1A1TSHRGAA
SCHEMBL12850742 0.79 HPGDS (0.47) HPGDSHTTALDH1A1CDC7MAP4K4
SCHEMBL11162210 0.78 EGFR (0.61) EGFRHTTKDM4EALDH1A1TP53
SCHEMBL30503636 0.78 EGFR (0.61) EGFRHTTKDM4EALDH1A1TP53
Aniline SCHEMBL28107592 0.78 ALDH1A1 (0.49) HPGDSHTTKDM4EALDH1A1CDC7
SCHEMBL63442 0.76 ALDH1A1 (0.57) EGFRHPGDSKDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3983064-B1 COT MODULATORS AND METHODS OF USE THEREOF GILEAD SCIENCES INC (US) 2024-03-06 EP disclosed
CN-112679473-B Lenatinib intermediate crystal, preparation method and application thereof 四川科伦药物研究院有限公司 2024-03-05 CN disclosed
CN-109422755-B Nitrogen-containing heterocyclic compound, preparation method, intermediate, composition and application 上海医药集团股份有限公司 2023-07-04 CN disclosed
CN-112679473-A Lenalitinib intermediate crystal, preparation method and application thereof 四川科伦药物研究院有限公司 2021-04-20 CN disclosed
CN-108026067-B 6-amino-quinoline-3-carbonitriles as COT modulators 吉利德科学公司 2021-01-12 CN disclosed
CN-108026067-B 6-amino-quinoline-3-carbonitriles as COT modulators 吉利德科学公司 2021-01-12 CN disclosed
CN-108026067-A 6- amino-quinolin -3- nitriles as COT conditioning agents 吉利德科学公司 2018-05-11 CN disclosed
CN-108026067-A 6- amino-quinolin -3- nitriles as COT conditioning agents 吉利德科学公司 2018-05-11 CN disclosed
EP-2896612-A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors Wyeth Holdings LLC (US) 2015-07-22 EP disclosed
CN-102146084-B 3-cyan-6-aminoquinoline derivatives, preparation method thereof and application thereof in medicines JIANGSU HENGRUI MEDICINE CO 2014-05-07 CN disclosed
EP-1117659-B1 SUBSTITUTED 3-CYANOQUINOLINES AS PROTEIN TYROSINE KINASES INHIBITORS WYETH CORP (US) 2003-12-03 EP disclosed
CN-1419559-A Tricyclic protein kinase inhibitors WYETH CORP (US) 2003-05-21 CN disclosed
CN-1320121-A Substituted 3-cyanoquinolines as protein tyrosine kinase inhibitors AMERICAN CYANAMID CO (US) 2001-10-31 CN disclosed
CN-1320118-A Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors AMERICAN CYANAMID CO (US) 2001-10-31 CN disclosed
US-6297258-B1 USEFUL AS ANTINEOPLASTIC AGENTS AND IN THE TREATMENT OF POLYCYSTIC KIDNEY DISEASE. AMERICAN CYANAMID COMPANY 2001-10-02 US disclosed
US-6288082-B1 COMPOUNDS SUCH AS 6,7-DIETHOXY-4-(INDAN-5-YLAMINO) -QUINOLINE-3-CARBONITRILE USED AS ANTINEOPLASTIC AGENTS AND IN THE TREATMENT OF POLYCYCSTIC KIDNEY DISEASE AMERICAN CYANAMID COMPANY 2001-09-11 US disclosed
EP-1117659-A1 SUBSTITUTED 3-CYANOQUINOLINES AS PROTEIN TYROSINE KINASES INHIBITORS American Cyanamid Company (US) 2001-07-25 EP disclosed
EP-1117649-A1 SUBSTITUTED 3-CYANOQUINOLINES AS PROTEIN TYROSINE KINASES INHIBITORS American Cyanamid Company (US) 2001-07-25 EP disclosed
WO-2000018740-A1 SUBSTITUTED 3-CYANOQUINOLINES AS PROTEIN TYROSINE KINASES INHIBITORS AMERICAN CYANAMID COMPANY (US) 2000-04-06 WO disclosed
WO-2000018761-A1 SUBSTITUTED 3-CYANOQUINOLINES AS PROTEIN TYROSINE KINASES INHIBITORS AMERICAN CYANAMID COMPANY (US) 2000-04-06 WO disclosed